Every earnings season has its share of outperformers, companies that report blowout quarters and raise their forecasts. The ...

Its weight-loss efficacy doubles that of Wegovy in shorter 3-month periods, and its pill configuration convenience should ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Novo’s once-weekly drug, CagriSema, combines semaglutide with another medicine called cagrilintide. The company predicts the ...

Rising numbers of people are needing hospital treatment for side effects from weight loss injections, and it may be affecting ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Novo Nordisk (CSE: NOVOb) has been placed on JPMorgan’s Catalyst Watch list, signaling heightened anticipation as the company approaches a pivotal moment in its ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

The Mounjaro manufacturer, Eli Lilly, said patient safety was the company’s top priority. The tragic case highlights the fact ...